Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients

V Monteón-Padilla1, N Hernández-Becerril, M A Ballinas-Verdugo

  • 1Laboratorio de Inmunoparasitología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico. victormonteon@hotmail.com

Insights

Molecular methods detect persistent Trypanosoma cruzi in chronic chagasic cardiopathy patients, even with low parasitemia. This parasite persistence may drive ongoing immune responses and disease progression.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Molecular Biology

Background:

  • Patients with chronic chagasic cardiopathy exhibit strong immune responses to Trypanosoma cruzi but have low, transient parasitemia.
  • Conventional diagnostic methods often fail to detect parasite persistence in these patients.
  • Molecular biology offers sensitive tools to identify parasite presence, crucial for understanding Chagas disease pathogenesis.

Purpose of the Study:

  • To investigate the persistence of Trypanosoma cruzi in patients with chronic chagasic cardiopathy using molecular techniques.
  • To compare the sensitivity of hemoculture and PCR for detecting Trypanosoma cruzi in blood samples.
  • To examine parasite presence in cardiac tissues of a chronic chagasic cardiopathy necropsy case.

Main Methods:

  • Studied 16 patients with chronic chagasic cardiopathy from Mexico, confirmed by clinical evaluation and antibodies to Trypanosoma cruzi.
  • Collected blood samples for hemoculture and Polymerase Chain Reaction (PCR) analysis.
  • Analyzed archival cardiac tissues from a necropsy case using immunohistochemistry and PCR.

Main Results:

  • Hemoculture detected Trypanosoma cruzi in 31% of patients, predominantly in the 25-40 age group.
  • PCR demonstrated parasite presence in 81% of patients, indicating higher sensitivity than hemoculture.
  • Parasitemia levels did not correlate with clinical findings or antibody titers. The autopsy case revealed parasite antigens and DNA in heart tissues.

Conclusions:

  • Chronic chagasic cardiopathy is associated with persistent Trypanosoma cruzi infection, even with undetectable parasitemia.
  • The continuous parasite presence may sustain immune stimulation, potentially contributing to pathogenic immune or autoimmune damage.
  • Molecular diagnostics are essential for revealing parasite persistence in chronic Chagas disease.
Abstract

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...